AIP
DNTH icon

Ameritas Investment Partners’s Dianthus Therapeutics DNTH Stock Holding History

Ameritas Investment Partners’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Buy
4,295
+1,361
+46% +$119K 0.01% 972
2026
Q1 		$246K Buy
2,934
+948
+48% +$54.9K 0.01% 1144
2025
Q4 		$81.8K Buy
1,986
+613
+45% +$23.8K ﹤0.01% 1819
2025
Q3 		$54K Sell
1,373
-969
-41% -$24.8K ﹤0.01% 2067
2025
Q2 		$43.6K Hold
2,342
– – ﹤0.01% 2271
2025
Q1 		$42.5K Hold
2,342
– – ﹤0.01% 2202
2024
Q4 		$51.1K Hold
2,342
– – ﹤0.01% 2167
2024
Q3 		$64.1K Hold
2,342
– – ﹤0.01% 2048
2024
Q2 		$60.6K Buy
+2,342
New +$56.3K ﹤0.01% 2035
2022
Q2 		– Sell
-107
Closed -$5K – 3109
2022
Q1 		$5K Hold
107
– – ﹤0.01% 2962
2021
Q4 		$8K Hold
107
– – ﹤0.01% 2953
2021
Q3 		$13K Hold
107
– – ﹤0.01% 2868
2021
Q2 		$17K Hold
107
– – ﹤0.01% 2810
2021
Q1 		$20K Hold
107
– – ﹤0.01% 2556
2020
Q4 		$13K Hold
107
– – ﹤0.01% 2675
2020
Q3 		$12K Hold
107
– – ﹤0.01% 2628
2020
Q2 		$13K Hold
107
– – ﹤0.01% 2571
2020
Q1 		$11K Buy
107
+33
+45% +$6.12K ﹤0.01% 2489
2019
Q4 		$18K Hold
74
– – ﹤0.01% 2458
2019
Q3 		$12K Hold
74
– – ﹤0.01% 2651
2019
Q2 		$18K Hold
74
– – ﹤0.01% 2503
2019
Q1 		$20K Buy
74
+53
+252% +$9.14K ﹤0.01% 2372
2018
Q4 		$2K Hold
21
– – ﹤0.01% 2947
2018
Q3 		$4K Buy
+21
New +$4.42K ﹤0.01% 2964

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Ameritas Investment Partners's DNTH Position: Q2 2026 in Review

Ameritas Investment Partners increased its Dianthus Therapeutics (DNTH) stake by 46% in Q2 2026, buying an estimated $119K and bringing the position to 4,295 shares worth $419K. The position accounts for 0.01% of the portfolio, ranked #972.

Ameritas Investment Partners first reported a position in DNTH in Q3 2018 and has held it in 24 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Ameritas Investment Partners held 4,295 shares of Dianthus Therapeutics worth $419K as of Q2 2026.
  • Ameritas Investment Partners bought 1,361 Dianthus Therapeutics shares in Q2 2026, an estimated $119K.
  • Dianthus Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #972 holding.
  • Ameritas Investment Partners first reported a position in Dianthus Therapeutics in Q3 2018 and has held it in 24 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.